Medovate

Medovate develops, manufactures and commercialises medical devices, working with clinical innovators and the NHS. Its products include SAFIRA, a regional anaesthesia system that makes the procedure a single-operator process with a built-in mechanism limiting injection pressure, and CAMPROBE, a device for transperineal prostate biopsies. A veterinary version of SAFIRA is also in its product range. Its JEB Manufacturing Services division designs, assembles and manufactures medical and industrial products.

Services cover idea development, design and development, manufacturing, regulatory and quality compliance, market introduction and adoption support through partners and distributors. Customers include clinical inventors, healthcare providers and distributors, and the company is seeking distributors in territories where exclusive distributors have not yet been appointed.

Medovate was founded in 1972 and was spun out of the NHS in 2017. Its predecessor, JEB Technologies, began medical manufacturing in 2003 and gained ISO 13485 accreditation in 2004. SAFIRA launched in the UK in 2020 and CAMPROBE in the UK and Europe in 2022. The company is headquartered in Mildenhall, UK, and Medovate Private Limited became operational in India in 2026. Medovate also offers apprenticeships in engineering and technical roles.

Product: SAFIRA regional anaesthesia system, CAMPROBE transperineal prostate biopsy device, and JEB contract manufacturing of medical and industrial products.